APA aipamena

Druce, K. L., Iqbal, K., Watson, K. D., Symmons, D. P. M., Hyrich, K. L., & Kelly, C. (2017). Mortality in patients with interstitial lung disease treated with rituximab or TNFi as a first biologic. RMD Open.

Chicago Style aipamena

Druce, Katie L., Kundan Iqbal, Kath D. Watson, Deborah P M. Symmons, Kimme L. Hyrich, and Clive Kelly. "Mortality in Patients With Interstitial Lung Disease Treated With Rituximab or TNFi As a First Biologic." RMD Open 2017.

MLA aipamena

Druce, Katie L., et al. "Mortality in Patients With Interstitial Lung Disease Treated With Rituximab or TNFi As a First Biologic." RMD Open 2017.